Abdulrafeh Naqash to National Cancer Institute (U.S.)
This is a "connection" page, showing publications Abdulrafeh Naqash has written about National Cancer Institute (U.S.).
Connection Strength
0.251
-
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program. J Clin Oncol. 2022 10 10; 40(29):3439-3452.
Score: 0.203
-
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute. Oncologist. 2021 10; 26(10):e1883-e1886.
Score: 0.048